Artiva Allogeneic NK

Other News

A time like no other for lupus clinical research

On “Endpoints Clinical Trials Day,” Lupus Therapeutics EVP Expresses Optimism About the Current State of Lupus Research

New York, NY, December 17, 2024 — Today is “Endpoints Clinical Trials Day,” hosted by international biopharma news outlet Endpoints News....

Request for Applications: see article for details

Lupus Therapeutics Announces a New, Groundbreaking Mechanism to Fund Clinical Studies Addressing the Impact of Diet, Nutrition, and Microbiome on Lupus

New York, NY, November 22, 2024 — The unique IDEAL (Investigate Dietary Approaches for Lupus) Initiative will provide multidisciplinary research teams the...

LRA Spotlight on ACR Convergence 2024: Lupus Therapeutics-Supported Clinical Research and More

New York, NY, November 21, 2024 — New ACR guidelines for advancing the management of lupus nephritis (LN). Novel approaches...